New pill shows promise for arthritis sufferers in early trial
NCT ID NCT07335952
First seen Jan 13, 2026 · Last updated May 20, 2026 · Updated 15 times
Summary
This study tested a new daily medication called Proximod for people with moderate-to-severe rheumatoid arthritis who did not get enough relief from standard treatments. 179 participants took either a low or high dose of Proximod or a placebo for three months. The goal was to see if the drug reduces joint pain and swelling better than a placebo, and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chun Li
Beijing, Beijing Municipality, 100044, China
-
Guixiu Shi
Xiamen, Fujian, 361003, China
-
Hua Zhang
Zaozhuang, Shandong, 277100, China
-
Huaxiang Wu
Hangzhou, Zhejiang, 310009, China
-
Jian Wu
Suzhou, Jiangsu, 215006, China
-
Jiashun Zeng
Guiyang, Guizhou, 550004, China
-
Ling Lei
Nanning, Guangxi, 530021, China
-
Lingli Dong
Wuhan, Hubei, 430030, China
-
Mei Tian
Zunyi, Guizhou, 563099, China
-
Mingwei Deng
Guangzhou, Guangdong, China
-
Qingwen Wang
Shenzhen, Guangdong, 518036, China
-
Senhua Dai
Pingxiang, Jiangxi, 337055, China
-
Shulin Song
Yichang, Hubei, 43003, China
-
Weiqi Min
Heze, Shandong, 274006, China
-
Wubin Long
Chengdu, Sichuan, 610072, China
-
Xiaofei Shi
Luoyang, Henan, 471000, China
-
Xuebinwang
Binzhou, Shandong, 256603, China
-
Yanmei Wu
Panjin, Liaoning, 124000, China
-
Yi He
Guangzhou, Guangdong, 510630, China
-
Zili Fu
Taiyuan, Shanxi, 030001, China
Conditions
Explore the condition pages connected to this study.